D-0575-2025 Class II Ongoing
FDA drug recall D-0575-2025 was initiated by Pfizer on Jul 29, 2025 and is designated Class II. Reason for recall: Subpotent drug The recall status is ongoing. Affected quantity: 29, 004 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 20, 2025
- Initiation Date
- Jul 29, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 29, 004 bottles
Product description
Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York, NY 10017, Made in Austria, NDC 60793-851-01.
Reason for recall
Subpotent drug
Distribution pattern
Within U.S
Code information
Lot #: 24C11, Exp 2/28/2026.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0575-2025
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Pfizer? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.